Moderna Inc MRNA is trading lower Wednesday after Denmark paused use of the company's COVID-19 vaccine for people under 18 years of age. Sweden also paused use of the vaccine for people born in 1991 and later.
Denmark and Sweden now recommend individuals in the younger age group opt for the Comirnaty vaccine from Pfizer Inc PFE and BioNTech SE BNTX instead.
Moderna is a pharmaceutical and biotechnology company focused on vaccine technologies based on mRNA. It's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020.
See Also: Why This Investor Keeps Buying Moderna Shares As The Stock Falls
MRNA Price Action: Moderna has traded as high as $497.49 and as low as $65.48 over a 52-week period.
The stock was down 4.9% at $315.71 at time of publication.
Photo: Mufid Majnun from Pixabay.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
